IDEXX Laboratories Inc (IDXX) Stock Forecast
US · Healthcare
Current price
$554.94
Market cap
$43.78B
Mean price target
$709.14
Implied upside
27.8%
Key takeaways
- Analysts rate IDEXX Laboratories Inc a “None”, with a mean price target of $709.14 — about 27.8% upside from the current $554.94, based on 14 analysts.
- IDXX is trading near its 52-week low, at 18% of the $506.91–$769.98 band.
Analyst consensus
| Consensus rating | None |
|---|---|
| Number of analysts | 14 |
| Mean target | $709.14 |
| High target | $805.00 |
| Low target | $470.00 |
| Rating split (SB / B / H / S / SS) | 4 / 5 / 5 / 0 / 1 |
Price & trading
| Current price | $554.94 |
|---|---|
| Previous close | $549.16 |
| 52-week high | $769.98 |
| 52-week low | $506.91 |
| 50-day average | $560.14 |
| Beta | 1.54 |
See the full IDXX breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current IDEXX Laboratories Inc (IDXX) share price?
- IDEXX Laboratories Inc last traded at $554.94 with a market capitalisation of about $43.8B.
- What is the analyst price target for IDXX?
- The mean analyst price target for IDEXX Laboratories Inc is $709.14, roughly 27.8% above the latest price. The current consensus rating is “None”.
- Where can I see IDEXX Laboratories Inc's full financial metrics?
- Luminoso tracks IDXX's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.